Cardlytics Inc (NASDAQ: CDLX) flaunted slowness of -2.30% at $3.83, before settling in for the price of $3.92 at the close. Taking a more long-term approach, CDLX posted a 52-week range of $2.89-$20.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Communication Services Sector giants’ yearly sales growth during the last 5-year period was 17.35%. Meanwhile, its Annual Earning per share during the time was -5.75%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 56.50%. This publicly-traded company’s shares outstanding now amounts to $49.84 million, simultaneously with a float of $47.38 million. The organization now has a market capitalization sitting at $190.89 million.
Cardlytics Inc (CDLX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Cardlytics Inc industry. Cardlytics Inc’s current insider ownership accounts for 4.94%, in contrast to 68.56% institutional ownership. According to the most recent insider trade that took place on Oct 02 ’24, this organization’s Chief Financial Officer sold 7,487 shares at the rate of 3.08, making the entire transaction reach 23,097 in total value, affecting insider ownership by 97,849. Preceding that transaction, on Oct 02 ’24, Company’s Chief Legal & Privacy Officer sold 5,936 for 3.08, making the whole transaction’s value amount to 18,313. This particular insider is now the holder of 85,445 in total.
Cardlytics Inc (CDLX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
Cardlytics Inc’s EPS increase for this current 12-month fiscal period is 56.50% and is forecasted to reach -1.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 44.10% through the next 5 years, which can be compared against the -5.75% growth it accomplished over the previous five years trading on the market.
Cardlytics Inc (NASDAQ: CDLX) Trading Performance Indicators
Let’s observe the current performance indicators for Cardlytics Inc (CDLX). It’s Quick Ratio in the last reported quarter now stands at 1.77. The Stock has managed to achieve an average true range (ATR) of 0.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.62.
In the same vein, CDLX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.83, a figure that is expected to reach -0.57 in the next quarter, and analysts are predicting that it will be -1.57 at the market close of one year from today.
